Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-25-008565

Options or other derivatives

  • Director acquired 1,517 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mahery Amy · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-17 Grant or award : show line 1 in the form Option to purchase common stock +1,517 1,517 D
Loading xslF345X05/ownership.xml…